GR 63799X, an EP3 receptor agonist, induced S phase arrest and 3T6 fibroblast growth inhibition

European Journal of Pharmacology

Volumn 529, Issue 1-3, 2006, Pages 16-23

  Sanchez, Teresa ^a   Moreno, Juan J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

cAMP; Cell cycle; Cell proliferation; Cyclin; Prostaglandin E2

Indexed keywords

CYCLIC AMP; FORSKOLIN; GR 63799X; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROSTANOID RECEPTOR; PROSTAGLANDIN E; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN EP3 RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; BIOACCUMULATION; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; FIBROBLAST; GROWTH INHIBITION; IC 50; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; ANIMAL; CELL CYCLE S PHASE; CELL LINE; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; MOUSE;

ANIMALS; CELL LINE; CELL PROLIFERATION; CYCLIC AMP; FIBROBLASTS; MICE; PROSTAGLANDINS E, SYNTHETIC; RECEPTORS, PROSTAGLANDIN E; S PHASE;

EID: 29344465614     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.10.040     Document Type: Article

References (40)

1. L.P. Audoly, L. Ma, I. Feoktistov, S. De Foe, M.D. Breyer, and R.M. Breyer Prostaglandin E-prostanoid-3 receptor activation of cyclic AMP response element mediated gene transcription J. Pharmacol. Exp. Ther. 289 1999 140 148
2. D. Bishop-Bailey, S. Calatayud, J.D. Warner, T. Hla, and J.A. Mitchell Prostaglandin and the regulation of tumor growth J. Environ. Pathol. Toxicol. Oncol. 21 2002 93 101
3. M.M. Bradford A rapid and sensitive method for the quantification of microgram quantities of protein using the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
4. 2 J. Biol. Chem. 174 1999 11660 11666
5. 3 receptors Adv. Prostaglandin Thromboxane Leukotrienes Res. 21A 1991 379 382
6. T.A. Chan, P.M. Hwang, H. Hermeking, K.W. Kinzler, and B. Vogelstein Cooperative effects of genes controlling the G(2)/M checkpoint Genes Dev. 14 2000 1584 1588
7. R.A. Coleman, W.L. Smith, S. Narumiya International Union of Pharmacology Classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes Pharmacol. Rev. 46 1994 205 221
8. R.N. Dubois, S.B. Abramson, L. Crofford, R.A. Gupta, L.S. Simon, L.B. Van De Putte, and P.E. Lipsky Cycloxygenase in biology and disease FASEB J. 12 1998 1063 1073
9. 1/S-regulatory genes Mol. Cell. Biol. 15 1995 4215 4224
10. 2 inhibits cAMP production and promotes platelet aggregation J. Clin. Invest. 107 2001 603 610
11. 3 receptor signaling J. Biochem. 131 2002 781 784
12. M.D. Houslay, and W. Kolch Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling Mol. Pharmacol. 58 2000 659 668
13. 3 subtypes Biochim. Biophys. Acta 140 1998 221 234
14. M. Kiriyama, F. Ushikubi, T. Kobayashi, M. Hirata, Sugimoto, and S. Narumiya Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptor expressed in Chinese hamster ovary cells Br. J. Pharmacol. 122 1997 217 224
15. K.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
16. S. Lloret, M. Torrent, and J.J. Moreno Proliferation-dependent changes in arachidonic acid mobilization from phospholipids of 3T6 fibroblasts Pflügers Arch. Eur. J. Physiol. 432 1996 655 662
17. C. Lukas, C.S. Sorensen, E. Kramer, E. Santoni-Rugiu, C. Lindeneg, J.M. Peters, J. Bartek, and J. Lukas Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex Nature 401 1999 815 818
18. H. Ma, A. Hara, C.Y. Xiao, Y. Okada, O. Takahata, K. Nakaya, Y. Sugimoto, A. Ichikawa, S. Narumiya, and F. Ushikushi Increased bleeding tendency and decreased susceptibility to thromboenbolism in mice lacking to prostaglandin E receptor subtype EP(3) Circulation 104 2001 1176 1180
19. J. Martínez, T. Sánchez, and J.J. Moreno Role of prostaglandin H synthase-2-mediated conversion of arachidonic acid in controlling 3T6 fibroblast growth Am. J. Physiol., Cell Physiol. 273 1997 C1466 C1471
20. waf1/Cip1/Sdi1 levels Biochim. Biophys. Acta 1538 2001 90 97
21. 3-receptor: cloning, expression and signal transduction Naunyn-Schmiedeberg's Arch. Pharmacol. 358 1998 160 167
22. J.J. Moreno Regulation of arachidonic acid release and prostaglandin formation by cell-cell adhesive interactions in wound repair Pflügers Arch. Eur. J. Physiol. 433 1997 351 356
23. 4 in colon carcinogenesis Cancer Res. 62 2002 28 32
24. S. Narumiya Prostanoid receptors. Structure, function, and distribution Ann. N.Y. Acad. Sci. 744 1994 126 138
25. S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid receptors: structures, properties and functions Physiol. Rev. 79 1999 1193 1226
26. 2 receptors in IL-1 beta-stimulated human gingival fibroblasts J. Periodontal Res. 37 2002 29 36
27. 2 alpha to regulate interaction of DNA replication and cell division in Swiss 3T3 cells Proc. Natl. Acad. Sci. U. S. A. 79 1982 4992 4996
28. J. Pines Cyclins and cyclin-dependent kinases: a biochemical view Biochem. J. 308 1995 697 711
29. 2 inhibitors on 3T6 fibroblast proliferation Biochem. Pharmacol. 61 2001 811 816
30. 2 subtype receptors in serum-induced 3T6 fibroblast cycle progression and proliferation Am. J. Physiol., Cell Physiol. 282 2002 C280 C288
31. K.B. Seamon, and J.W. Daly Forskolin: its biological and chemical properties Adv. Cycl. Nucleotide Protein Phosphoryl. Res. 20 1986 1 150
32. C.J. Sherr Cancer cell cycles Science 274 1996 1672 1677
33. M.I. Simon, M.P. Strathmann, and N. Gautam Diversity of G proteins in signal transduction Science 152 1991 802 808
34. W.L. Smith Prostanoid biosynthesis and mechanisms of action Am. J. Physiol., Renal Fluid Electrolyte Physiol. 263 1992 F181 F191
35. T. Watanabe, H. Satoh, M. Togoh, S. Taniguchi, Y. Hashimoto, and K. Kurokawa Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells J. Cell. Physiol. 169 1996 401 409
36. K. Watanabe, T. Kawamori, S. Nakatsugi, T. Ohta, S. Ohuchida, H. Yamamoto, T. Maruyama, K. Kondo, F. Ushikubi, S. Narumiya, T. Sugimura, and K. Wakabayashi Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis Cancer Res. 59 1999 5093 5096
37. T. Yano, G. Zissel, J. Muller-Qernheim, S. Jae Shin, H. Satoh, and T. Ichikawa Prostaglandin E2 reinforces the activation of ras signal pathway in lung adenocarcinoma cells via EP3 FEBS Lett. 518 2002 154 158
38. 2 in interleukin-1α-induced parathyroid hormone-related peptide production in synovial fibroblasts of patients with rheumatoid arthritis J. Clin. Endocrinol. Metab. 86 2001 3272 3278
39. J. Yu, G.N. Prado, B. Schreiber, P. Polgar, P. Polgar, and L. Taylor Role of prostaglandin E2 EP receptor and cAMP in the expression of connective tissue growth factor Arch. Biochem. Biophys. 404 2002 302 308
40. K. Zacharowski, and C. Thiemermann Pharmacology of the prostaglandin EP3 receptor agonist TEI-3356 Cardiovasc. Drug Rev. 17 1999 329 340